Morgan Stanley Has Lowered Expectations for Cytek Biosciences (NASDAQ:CTKB) Stock Price
Cytek Biosciences (NASDAQ:CTKB – Free Report) had its price objective reduced by Morgan Stanley from $9.00 to $7.00 in a report issued on Wednesday morning,Benzinga reports. They currently have an equal weight rating on the stock. Other equities research analysts have also recently issued research reports about the stock. TD Cowen cut shares of Cytek […]
Cytek Biosciences (NASDAQ:CTKB – Free Report) had its price objective reduced by Morgan Stanley from $9.00 to $7.00 in a report issued on Wednesday morning,Benzinga reports. They currently have an equal weight rating on the stock. Other equities research analysts have also recently issued research reports about the stock. TD Cowen cut shares of Cytek […]
